He completed his PhD in November 2022, focusing on the role of integrin signalling in pressure overload–induced cardiac remodeling. He currently serves as Work Package Leader for statistical analysis in BIOTOOL-CHF, a European HORIZON-funded initiative developing biomarker-based tools to improve the diagnosis and management of cardiac congestion.

Within the team, he focuses on heart transplantation, investigating donor-derived cell-free DNA (dd-cfDNA) and transcriptomic profiling to assess rejection in cardiac transplant patients.